Aridis Pharmaceuticals Inc (ARDS)

Trade ARDS now with
8/12/2019 4:21:50 PM Aridis Pharma Q2 Loss/share $1.03 Vs. Loss $11.78 Year Ago
7/30/2019 5:49:31 AM Aridis Pharma Enters Equity Purchase And Option Agreements With The Serum Institute Of India
7/19/2019 5:58:23 AM Aridis Pharma Receives Orphan Drug Designation From EMA For AR-501
6/27/2019 5:32:26 AM Aridis Says FDA Granted Orphan Drug Designation To AR-501
6/10/2019 5:31:13 AM Aridis Pharmaceuticals Appoints Susan Windham-Bannister To Its Board
5/14/2019 4:41:13 PM Aridis Pharma Q1 Loss/share $0.99 Vs. Loss $48.99 Year Ago
3/28/2019 4:12:00 PM Aridis Pharmaceuticals Q4 Loss/share $0.67 Vs. Loss $34.34 Year Ago
12/12/2018 7:34:53 AM Aridis : AR-501 Enrolls First Subject In Phase 1/2a Trial For Treatment Of Chronic Lung Infections In CF Patients
11/7/2018 7:35:19 AM Aridis Pharma Publishes Positive AR-301 Phase 1/2a Data In Intensive Care Medicine And The Lancet Respiratory Medicine
8/13/2018 12:29:24 AM This Week's Biotech IPOs